Literature DB >> 31371380

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML.

Tracy Murphy1, Jinfeng Zou1, Georgina S Daher-Reyes1, Andrea Arruda1, Vikas Gupta1, Caroline J McNamara1, Mark D Minden1, Aaron D Schimmer1, Hassan Sibai1, Karen W L Yee1, Mariam Korulla1,2,3, Tracy Stockley1,2,3, Suzanne Kamel-Reid1,2,3, Dawn Maze1, Anne Tierens1,2,3, Scott V Bratman1, Andre C Schuh1, Steven M Chan1.   

Abstract

Entities:  

Year:  2019        PMID： 31371380      PMCID： PMC6693012          DOI： 10.1182/bloodadvances.2019000306

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  17 in total

1.  The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.

Authors:  L A GAYDOS; E J FREIREICH; N MANTEL
Journal:  N Engl J Med       Date:  1962-05-03       Impact factor: 91.245

2.  Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.

Authors:  Sarah A Buckley; Megan Othus; Vladimir Vainstein; Janis L Abkowitz; Elihu H Estey; Roland B Walter
Journal:  Am J Hematol       Date:  2014-02-24       Impact factor: 10.047

3.  Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.

Authors:  Robert B Gerbing; Todd A Alonzo; Lillian Sung; Alan S Gamis; Soheil Meshinchi; Sharon E Plon; Alison A Bertuch; Maria M Gramatges
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

4.  Dnmt3a is essential for hematopoietic stem cell differentiation.

Authors:  Grant A Challen; Deqiang Sun; Mira Jeong; Min Luo; Jaroslav Jelinek; Jonathan S Berg; Christoph Bock; Aparna Vasanthakumar; Hongcang Gu; Yuanxin Xi; Shoudan Liang; Yue Lu; Gretchen J Darlington; Alexander Meissner; Jean-Pierre J Issa; Lucy A Godley; Wei Li; Margaret A Goodell
Journal:  Nat Genet       Date:  2011-12-04       Impact factor: 38.330

5.  Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis.

Authors:  Christopher Maximilian Arends; Joel Galan-Sousa; Kaja Hoyer; Willy Chan; Marten Jäger; Kenichi Yoshida; Ricarda Seemann; Daniel Noerenberg; Nils Waldhueter; Helga Fleischer-Notter; Friederike Christen; Clemens A Schmitt; Bernd Dörken; Uwe Pelzer; Marianne Sinn; Tomasz Zemojtel; Seishi Ogawa; Sven Märdian; Adrian Schreiber; Annegret Kunitz; Ulrike Krüger; Lars Bullinger; Elena Mylonas; Mareike Frick; Frederik Damm
Journal:  Leukemia       Date:  2018-03-01       Impact factor: 11.528

6.  Detecting ultralow-frequency mutations by Duplex Sequencing.

Authors:  Scott R Kennedy; Michael W Schmitt; Edward J Fox; Brendan F Kohrn; Jesse J Salk; Eun Hyun Ahn; Marc J Prindle; Kawai J Kuong; Jiang-Cheng Shen; Rosa-Ana Risques; Lawrence A Loeb
Journal:  Nat Protoc       Date:  2014-10-09       Impact factor: 13.491

7.  Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.

Authors:  Myunggon Ko; Hozefa S Bandukwala; Jungeun An; Edward D Lamperti; Elizabeth C Thompson; Ryan Hastie; Angeliki Tsangaratou; Klaus Rajewsky; Sergei B Koralov; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

8.  Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB.

Authors:  E H Estey; Y Shen; P F Thall
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

9.  The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia.

Authors:  Runxia Gu; Hui Wei; Ying Wang; Dong Lin; Bingcheng Liu; Chunlin Zhou; Kaiqi Liu; Benfa Gong; Shuning Wei; Guangji Zhang; Xiaoyuan Gong; Yuntao Liu; Yan Li; Xingli Zhao; Shaowei Qiu; Huijun Wang; Min Wang; Yingchang Mi; Jianxiang Wang
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

10.  Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Authors:  Maja Rothenberg-Thurley; Susanne Amler; Dennis Goerlich; Thomas Köhnke; Nikola P Konstandin; Stephanie Schneider; Maria C Sauerland; Tobias Herold; Max Hubmann; Bianka Ksienzyk; Evelyn Zellmeier; Stefan K Bohlander; Marion Subklewe; Andreas Faldum; Wolfgang Hiddemann; Jan Braess; Karsten Spiekermann; Klaus H Metzeler
Journal:  Leukemia       Date:  2018-02-23       Impact factor: 11.528
View more
  4 in total

1.  Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase.

Authors:  Vikas Gupta; James A Kennedy; Jose-Mario Capo-Chichi; Soyoung Kim; Zhen-Huan Hu; Edwin P Alyea; Uday R Popat; Ronald M Sobecks; Bart L Scott; Aaron T Gerds; Rachel B Salit; H Joachim Deeg; Ryotara Nakamura; Wael Saber
Journal:  Blood Adv       Date:  2020-11-10

Review 2.  Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia.

Authors:  Robert P Hasserjian; David P Steensma; Timothy A Graubert; Benjamin L Ebert
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

3.  Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.

Authors:  Tomoyuki Tanaka; Kiyomi Morita; Sanam Loghavi; Feng Wang; Ken Furudate; Yuya Sasaki; Latasha Little; Curtis Gumbs; Jairo Matthews; Naval Daver; Naveen Pemmaraju; Courtney D DiNardo; Koji Sasaki; Musa Yilmaz; Tapan M Kadia; Farhad Ravandi; Marina Y Konopleva; Hagop M Kantarjian; Richard E Champlin; Gheath Al-Atrash; Guillermo Garcia-Manero; Sa A Wang; P Andrew Futreal; Koichi Takahashi
Journal:  Blood       Date:  2021-11-04       Impact factor: 22.113

4.  Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?

Authors:  Tsung-Chih Chen; Ren Ching Wang; Yu-Hui Lin; Kuang-Hsi Chang; Li-Ya Hung; Chieh-Lin Jerry Teng
Journal:  Ther Adv Hematol       Date:  2020-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.